News Headline Summary

FDA approves Celgene (CELG) Pomalidomide in multiple Myeloma

Reaction details:

- In reaction to this news co. shares moved 0.85% higher to trade at USD 100.86 last.

Print 20:31, 08 Feb 2013 - US Equities - Source: Newswires